连续性肾臟替代疗法市场－全球产业规模、份额、趋势、机会和预测，按产品、治疗方式、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球连续性肾臟替代疗法市场规模为13.2亿美元，预计2030年将以8.91%的复合年增长率成长至22亿美元。连续性肾臟替代疗法（CRRT）是一种体外血液净化技术，主要用于治疗重症监护病房中出现急性肾损伤或严重体液超负荷的重症患者。该市场的成长主要受以下因素驱动：全球急性肾损伤发病率不断上升、老年人口不断增长（老年人本身就更容易出现肾臟併发症）以及CRRT系统的技术不断进步。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球连续性肾臟替代疗法市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品分类（透析液和置换液、一次性用品、血液滤过器、血路输液器和导管、其他一次性用品、CRRT系统）
  • 依治疗方式（连续性静脉-静脉血液滤过（CVVH）、连续性静脉-静脉血液透析滤过（CVVHDF）、连续性静脉-静脉血液透析（CVVHD）、慢速连续超滤（SCUF））
  • 按最终使用者（医院和诊所、门诊手术护理、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美连续性肾臟替代疗法市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲连续性肾臟替代疗法市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区连续性肾臟替代疗法市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲连续性肾臟替代疗法市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲连续性肾臟替代疗法市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球连续性肾臟替代疗法市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Baxter International, Inc
• Fresenius Ag & Co.
• Nikkiso Co., Ltd
• Braun Melsungen Ag
• Medtronic Plc
• Asahi Kasei Corporation
• Toray Medical Co., Ltd.
• Informed SA
• Nipro Corporation
• Medica SPA

第十六章：策略建议

第17章调查会社について・免责事项

The Global Continuous Renal Replacement Therapy Market, valued at USD 1.32 Billion in 2024, is projected to experience a CAGR of 8.91% to reach USD 2.20 Billion by 2030. Continuous Renal Replacement Therapy (CRRT) represents a continuous extracorporeal blood purification technique employed for critically ill patients experiencing acute kidney injury or severe fluid overload, primarily within intensive care settings. The market's expansion is fundamentally driven by the escalating global incidence of acute kidney injury, the increasing geriatric population which inherently presents a higher predisposition to renal complications, and ongoing technological advancements in CRRT systems.

Key Market Drivers

The Global Continuous Renal Replacement Therapy market is significantly influenced by the increasing incidence of acute kidney injury and chronic kidney disease. These conditions frequently necessitate advanced renal support, directly expanding the patient pool eligible for CRRT. The widespread nature of renal ailments is underscored by recent findings, where according to EurekAlert! , in October 2025, reporting on the Global Burden of Disease Study 2023, kidney dysfunction was identified among the top ten risk factors for global health loss in 2023. This pervasive health challenge creates a continuous and growing demand for effective therapeutic interventions like CRRT.

Key Market Challenges

The substantial cost associated with Continuous Renal Replacement Therapy equipment and disposable sets represents a significant impediment to market expansion. This financial burden directly affects healthcare systems globally, particularly those operating under budget constraints, by limiting their capacity for equipment acquisition and sustained operational expenses. According to a study published in *Critical Care Explorations* in June 2023, the daily cost of CRRT was estimated to be approximately $872 from a U. S. healthcare payer perspective, indicating a considerable financial commitment for healthcare facilities.

Key Market Trends

The integration of artificial intelligence (AI) is significantly enhancing the precision and operational efficiency of Continuous Renal Replacement Therapy. AI algorithms can analyze extensive patient data to predict responses, optimize fluid balance, and automate medication dosing, thereby minimizing human error and supporting more consistent, tailored treatments in critical care. Fresenius Medical Care, in October 2023, announced its strategic initiative to develop AI models utilizing anonymized data from over 540,000 dialysis patients. This endeavor is aimed at refining various aspects of dialysis therapies, including the optimization of erythropoietin stimulating agents and iron therapies. Such advancements are critical for transitioning from reactive interventions to proactive, data-driven patient management. While the practical application of AI in CRRT is still developing, research into its potential to enhance CRRT delivery has seen substantial growth in recent years, highlighting its recognized importance within the industry.

Key Market Players

• Baxter International, Inc
• Fresenius Ag & Co.
• Nikkiso Co., Ltd
• Braun Melsungen Ag
• Medtronic Plc
• Asahi Kasei Corporation
• Toray Medical Co., Ltd.
• Informed SA
• Nipro Corporation
• Medica SPA

Report Scope:

In this report, the Global Continuous Renal Replacement Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Continuous Renal Replacement Therapy Market, By Product:

• Dialysates and Replacement Fluids
• Disposables
• Hemofilters
• Bloodline Sets & Tubes
• Other Disposables
• CRRT Systems

Continuous Renal Replacement Therapy Market, By Modality:

• Continuous venovenous hemofiltration (CVVH)
• Continuous venovenous hemodiafiltration (CVVHDF)
• Continuous venovenous hemodialysis (CVVHD)
• Slow continuous ultrafiltration (SCUF)

Continuous Renal Replacement Therapy Market, By End User:

• Hospital & Clinics
• Ambulatory Surgical care
• Others

Continuous Renal Replacement Therapy Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Continuous Renal Replacement Therapy Market.

Available Customizations:

Global Continuous Renal Replacement Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Continuous Renal Replacement Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Dialysates and Replacement Fluids, Disposables, Hemofilters, Bloodline Sets & Tubes, Other Disposables, CRRT Systems)
  • 5.2.2. By Modality (Continuous venovenous hemofiltration (CVVH), Continuous venovenous hemodiafiltration (CVVHDF), Continuous venovenous hemodialysis (CVVHD), Slow continuous ultrafiltration (SCUF))
  • 5.2.3. By End User (Hospital & Clinics, Ambulatory Surgical care, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Continuous Renal Replacement Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Modality
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Continuous Renal Replacement Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Modality
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Continuous Renal Replacement Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Modality
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Continuous Renal Replacement Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Modality
      • 6.3.3.2.3. By End User

7. Europe Continuous Renal Replacement Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Modality
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Continuous Renal Replacement Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Modality
      • 7.3.1.2.3. By End User
  • 7.3.2. France Continuous Renal Replacement Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Modality
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Continuous Renal Replacement Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Modality
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Continuous Renal Replacement Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Modality
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Continuous Renal Replacement Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Modality
      • 7.3.5.2.3. By End User

8. Asia Pacific Continuous Renal Replacement Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Modality
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Continuous Renal Replacement Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Modality
      • 8.3.1.2.3. By End User
  • 8.3.2. India Continuous Renal Replacement Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Modality
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Continuous Renal Replacement Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Modality
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Continuous Renal Replacement Therapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Modality
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Continuous Renal Replacement Therapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Modality
      • 8.3.5.2.3. By End User

9. Middle East & Africa Continuous Renal Replacement Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Modality
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Continuous Renal Replacement Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Modality
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Continuous Renal Replacement Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Modality
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Continuous Renal Replacement Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Modality
      • 9.3.3.2.3. By End User

10. South America Continuous Renal Replacement Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Modality
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Continuous Renal Replacement Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Modality
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Continuous Renal Replacement Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Modality
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Continuous Renal Replacement Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Modality
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Continuous Renal Replacement Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Baxter International, Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Fresenius Ag & Co.
• 15.3. Nikkiso Co., Ltd
• 15.4. Braun Melsungen Ag
• 15.5. Medtronic Plc
• 15.6. Asahi Kasei Corporation
• 15.7. Toray Medical Co., Ltd.
• 15.8. Informed SA
• 15.9. Nipro Corporation
• 15.10. Medica SPA

16. Strategic Recommendations

17. About Us & Disclaimer